Minocycline
Spécifications
10118-90-8Numéro CAS
(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamideNom IUPAC
C23H27N3O7Formule chimique
457.5 g/molMasse molaire
minocycline; 10118-90-8; Minocyclin; Minociclina; Minomycin; Dynacin; Minocin; (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE; Minocyn; 7-Dimethylamino-6-demethyl-6-deoxytetracycline; CL 59806; DTXSID1045033; FYY3R43WGO; Tri-minocycline; (4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide; 4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; Minocyclinum; CHEBI:50694; NSC 141993; Minocyclinum [INN-Latin]; NCGC00183044-01; Borymycin; Minociclina [INN-Spanish]; MIY; MINO; minociclinum; Minocline; Minoz; Mino-Tabs; 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-; HSDB 3130; NSC-141993; Minocin (Hydrochloride); Vectrin (Hydrochloride); UNII-FYY3R43WGO; Minocycline (USAN/INN); BRN 3077644; Lactoferrin B & Minocycline; Lactoferrin H & Minocycline; Minocycline [USAN:INN:BAN]; Minomycin;; SR-05000001675; (minocycline); Minoderm;; Aknemin;; Arestin;; Dynacin;; Minocin;; Sebomin;; Solodyn;; Akamin;; (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2- CARBOXAMIDE; (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide; NSC141993; Spectrum_000967; MINOCYCLINE [MI]; Prestwick0_000315; Prestwick1_000315; Prestwick2_000315; Spectrum2_001047; Spectrum3_000508; Spectrum4_000062; Spectrum5_001293; MINOCYCLINE [INN]; MINOCYCLINE [HSDB]; MINOCYCLINE [USAN]; MINOCYCLINE [VANDF]; SCHEMBL4042; CHEMBL1434; MINOCYCLINE [MART.]; SCHEMBL24315; BSPBio_002035; KBioGR_000583; KBioSS_001447; MINOCYCLINE [WHO-DD]; 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,12aalpha))-; DivK1c_000450; SPBio_000974; SPBio_002529; orb1989822; DTXCID9025033; SCHEMBL16681149; SCHEMBL29369923; SCHEMBL29416350; BCBcMAP01_000027; GTPL10831; KBio1_000450; KBio2_001447; KBio2_004015; KBio2_006583; KBio3_001535; NINDS_000450; HMS2090D03; KUC106429N; (4S,4aS,5aR,12aS)4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide;(4S,4aS,5aR,12aS)4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide; 2-NAPHTHACENECARBOXAMIDE, 4,7-BIS(DIMETHYLAMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-, (4S-(4.ALPHA.,4A.ALPHA.,5A.ALPHA.,12A.ALPHA.))-; KSC-12-231B; Tox21_113643; BDBM50103599; EBC-27149; HY-17412A; LMPK07000002; AKOS015969674; CL59806; DB01017; Minocycline; Tigecycline EP Impurity C; IDI1_000450; SMP1_000191; NCGC00178854-01; NCGC00178854-02; NCGC00188954-01; NCGC00482890-01; AC-30184; CL-59806; DA-65471; SBI-0051449.P003; CAS-10118-90-8; CS-0009521; NS00007904; TIGECYCLINE IMPURITY C [EP IMPURITY]; C07225; D05045; D78303; AB00053501-03; AB00053501_04; AB00053501_05; EN300-7481098; Q415336; T131626; SR-05000001675-3; (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-Synonymes
Produits contenant Minocycline
Entreprises vendant Minocycline
CT
Công ty cổ phần dược phẩm WealpharViet NamSP
STARWAY PHARM Co., Ltd.ChinaCT
Công ty TNHH dược phẩm Huy VănViet NamCT
Công ty cổ phần dược mỹ phẩm Bảo AnViet NamCT
Công ty cổ phần dược phẩm Phúc LongViet NamCT
Công ty TNHH Dược phẩm LamdaViet Nam